Vimarsana
Biggest News Aggregation in the World

Formycon Ag News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Formycon Ag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Formycon Ag Today - Breaking & Trending Today

Those who invested in Formycon (ETR:FYB) five years ago are up 114% - Vimarsana News

Those who invested in Formycon (ETR:FYB) five years ago are up 114%

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...

Source: yahoo.com
Related Topics:
Revenue GrowthFormycon Ag
Revenues Not Telling The Story For Formycon AG (ETR:FYB) - Vimarsana News

Revenues Not Telling The Story For Formycon AG (ETR:FYB)

Formycon AG's ( ETR:FYB ) price-to-sales (or "P/S") ratio of 13.2x might make it look like a strong sell right now...

Source: yahoo.com
Investegate |Formycon AG Announcements | Formycon AG: Formycon AG upsizes capital increase from authorized capital following strong demand - Vimarsana News

Investegate |Formycon AG Announcements | Formycon AG: Formycon AG upsizes capital increase from authorized capital following strong demand

Investegate announcements from Formycon AG, Formycon AG upsizes capital increase from authorized capital following strong demand

Investegate |Formycon AG Announcements | Formycon AG: Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab) - Vimarsana News

Investegate |Formycon AG Announcements | Formycon AG: Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)

Investegate announcements from Formycon AG, Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)

Investegate |Formycon AG Announcements | Formycon AG: Formycon AG plans capital increase of approx. 5% of the share capital by way of an accelerated bookbuilding procedure to finance further growth - Vimarsana News

Investegate |Formycon AG Announcements | Formycon AG: Formycon AG plans capital increase of approx. 5% of the share capital by way of an accelerated bookbuilding procedure to finance further growth

Investegate announcements from Formycon AG, Formycon AG plans capital increase of approx. 5% of the share capital by way of an accelerated bookbuilding procedure to finance further growth